Co-Authors
This is a "connection" page, showing publications co-authored by J Baillie and Michelle Girvan.
Connection Strength
0.353
-
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave. Lancet. 2021 09 18; 398(10305):1037-1038.
Score: 0.060
-
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021 07 17; 398(10296):223-237.
Score: 0.060
-
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021 Aug; 2(8):e354-e365.
Score: 0.059
-
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021 07; 9(7):773-785.
Score: 0.059
-
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021 Jul; 3(7):e498-e506.
Score: 0.059
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.056